BCL2A1 and ovarian neoplasm: In two pairs of patient samples (P15 and P21), the analysis indicated that the relative expression of BCL2A1 after normalization by β-actin was 1.6–3.7-fold higher in metastatic ovarian cancer cells isolated from lavage/ascites than in those from the paired primary ovarian tumors (Figure 3G).